Table 3 Variables for Secondary End Points and Adverse Events in each Group
Control group (n = 14) | Test Group 1 (n = 15) | Test Group 2 (n = 15) | p-value | |
|---|---|---|---|---|
Marking on breast lesion | ||||
Yes | 13 (92.9%) | 13 (86.7%) | 14 (93.3%) | 0.954 |
No | 1 (7.1%) | 2 (13.3%) | 1 (6.7%) | |
Marking on excised specimen | ||||
Yes | 13 (92.9%) | 14 (93.3%) | 15 (100.0%) | 0.357 |
No | 1 (7.1%) | 1 (6.7%) | 0 (0.0%) | |
Skin pigmentation | ||||
Yes | 9 (64.3%) | 0 (0.0%) | 0 (0.0%) | 0.000 |
No | 4 (28.6%) | 15 (100.0%) | 15 (100.0%) | U |
Unknown | 1 (7.1%) | 0 (0.0%) | 0 (0.0%) | |
Histopathological accuracy | ||||
Mean (±sd) | 0.3 (±0.1) | 0.4 (±0.1) | 0.4 (±0.1) | 0.331(group1-2) 0.389(group2-3) 0.914(group1-3) |
Adverse events (AEs) | ||||
Yes | 0(0.0%) | 0(0.0%) | 0(0.0%) | 1.000 |
No | 14(100.0%) | 15(100.0%) | 15(100.0%) | |